Conditional expression of hepatocyte nuclear factor-1β, the maturity-onset diabetes of the young-5 age product, influences the viability and functional competence of pancreatic β-cells

Journal of Endocrinology

Volumn 190, Issue 1, 2006, Pages 171-181

  Welters, Hannah J ^a   Senkel, Sabine ^b   Klein Hitpass, Ludger ^b   Erdmann, Silke ^b   Thomas, Heike ^b   Harries, Lorna W ^a   Pearson, Ewan R ^a   Bingham, Coralie ^a   Hattersley, Andrew T ^a   Ryffel, Gerhart U ^b   Morgan, Noel G ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GENE PRODUCT; HEPATOCYTE NUCLEAR FACTOR 1BETA; HOMEODOMAIN PROTEIN; INSULIN; MATURITY ONSET DIABETES MELLITUS YOUNG 5 PROTEIN; MESSENGER RNA; PROTEIN KINASE C; TRYPAN BLUE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL MEMBRANE DEPOLARIZATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DUODENUM; ENZYME ACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; INSULIN RELEASE; MATURITY ONSET DIABETES MELLITUS; NONHUMAN; NUTRIENT; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 33746721402     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06768     Document Type: Article

References (53)

1. Bach I & Yaniv M 1993 More potent transcriptional activators or a transdominant inhibitor of the HNF1 homeoprotein family are generated by alternative RNA processing. EMBO Journal 12 4229-4242.
2. Bach I, Mattei MG, Cereghini S & Yaniv M 1991 Two members of an HNF1 homeoprotein farfuly are expressed in human liver. Nucleic Acids Research 19 3553-3559.
3. Bai Y, Pontoglio M, Hiesberger T, Sinclair AM & Igarashi P 2002 Regulation of kidney-specific Ksp-cadherin gene promoter by hepatocyte nuclear factor-1beta. American Journal of Physiology. Renal Physiology 283 F839-F851.
4. Barbacci E, Reber M, Ott MO, Breillat C, Huetz F & Cereghim S 1999 Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development 126 4795-4805.
5. Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E & Melloul D 2001 A pancreatic beta-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. Journal of Biological Chemistry 276 17533-17540.
6. Bingham C & Hattersley AT 2004 Renal cysts and diabetes syndrome resulting from mutations in hepatocyte nuclear factor-1beta. Nephrology Dialysis, Transplantation 19 2703-2708.
7. Bingham C, Ellard S, Allen L, Bulman M, Shepherd M, Frayling T, Berry PJ, Clark PM, Lindner T, Bell GI et al. 2000 Abnormal nephron development associated with a frameshift mutation in the transcription factor hepatocyte nuclear factor-1 beta. Kidney International 57 898-907.
8. Cereghini S 1996 Liver-enriched transcription factors and hepatocyte differentiation. FASEB Journal 10 267-282.
9. Chakraborty M, Qiu SG, Vasudevan KM & Rangnekar VM 2001 Par-4 drives trafficking and activation of Fas and Fas1 to induce prostate cancer cell apoptosis and tumor regression. Cancer Research 61 7255-7263.
10. Coffinier C, Thepot D, Babinet C, Yaniv M & Barra j 1999 Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. Development 126 4785-4794.
11. Elliott J, Scarpello JH & Morgan NG 2002 Differential effects of genistein on apoptosis induced by fluoride and pertussis toxin in human and rat pancreatic islets and RINm5F cells. Journal ofEndoainology 172 137-143.
12. Erdmann KS 2003 The protein tyrosine phosphatase PTP-basophil/ basophil-like, interacting proteins and molecular functions. European Journal of Biochemistry/FEBS 270 4789-4798.
13. Erdmann KS, Kuhlmann J, Lessmann V, Herrmann L, Eulenburg V, Muller O & Heumann R 2000 The adenomatous polyposis coli-protein (APC) interacts with the protein tyrosine phosphatase PTP-BL via an alternatively spliced PDZ domain. Oncogene 19 3894-3901.
14. Fajans SS, Bell GI & Polonsky KS 2001 Molecular mechanisms and clinical pathophysiology of matrurity-onset diabetes of the young. New England Journal ofMedicine 345 971-980.
15. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J & Passa P 1993 Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. New England Journal of Medicine 328 697-702.
16. Gey G & Gey M 1936 Maintenance of human normal cells in continuous culture; preliminary report; cultivation of mesoblastic turnouts and normal cells and notes on methods of cultivation. American Journal of Cancer 2745-76.
17. Gresh L, Fischer E, Reimann A, Tanguy M, Garbay S, Shao X, Hiesberger T, Fiette L, Igarashi P, Yaniv M et al. 2004 A transcriptional network in polycystic kidney disease. EMBO Journal 23 1657-1668.
18. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ et al. 2005 Loss of ARNT/ HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122 337-349.
19. Harries LW, Ellard S, Jones PW, Hattersley AT & Bingham C 2004 Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome. Diabetologia 47 937-942.
20. Haumaitre C, Barbacci E, Jenny M, Ott MO, Gradwohl G & Cereghini S 2005 Lack of TCF2/vHNF1 in mice leads to pancreas agenesis. PNAS 102 1490-1495.
21. Herrmann L, Dittmar T & Erdmann KS 2003 The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis. Molecular Biology of the Cell 14 230-240.
22. Hildesheim J, Bulavin DV, Anver MR, Alvord WG, Hollander MC, Vardanian L & Fornace AJ Jr 2002 Gadd45a protects against UV irradiation-induced skin tumors, and promotes apoptosis and stress signaling via MAPK and p53. Cancer Research 62 7305-7315.
23. Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD et al. 1999 Genomic instability in Gadd45a-deficient mice. Nature Genetics 23 176-184.
24. Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O et al. 1997 Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nature Genetics 17 384-385.
25. Lee JY, Ristow M, Lin X, White MF, Magnuson MA & Hennighausen L 2006 RIP-Cre revisited: evidence for impairments of pancreatic β-cell function. Journal of Biological Chemistry 281 2649-2653.
26. Lindner TH, Njolstad PR, Horikawa Y, Bostad L, Bell GI & Sovik O 1999 A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-lbeta. Human Molecular Genetics 8 2001-2008.
27. +. Diabetes 49 418-423.
28. Maestro MA, Boj SF, Luco RF, Pierreux CE, Cabedo, J, Servitja JM, German MS, Rousseau GG, Lemaigre FP & Ferrer J 2003 Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Human Molecular Genetics 12 3307-3314.
29. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M & Krolewski AS 1999 Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nature Genetics 23 323-328.
30. Mendel DB, Hansen LP, Graves MK, Conley PB; & Crabtree GR 1991 HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Gene and Development 5 1042-1056.
31. Nishigori H, Yamada S, Kohama T, Tomura H, Sho K, Horikawa Y, Bell GI, Takeuchi T & Takeda J 1998 Frameshift mutation, A263fsinsGG, in the hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 47 1354-1355.
32. Owen K & Hattersley AT 2001 Maturity-onset diabetes of the young: from clinical description to molecular genetic characterization. Best Practice and Research. Clinical Endocrinology and Metabolism 15 309-323.
33. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM & Hattersley AT 2003 Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362 1275-1281.
34. Pearson ER, Badman MK, Lockwood CR, Clark PM, Ellard S, Bingham C & Hattersley AT 2004 Contrasting diabetes phenotypes associated with hepatocyte nuclear factor-1alpha and -1beta mutations. Diabetes Care 27 1102-1107.
35. Rangnekar VM 1998 Apoptosis mediated by a novel leucine zipper protein Par-4. Apoptosis 3 61-66
36. Ryffel GU 2001 Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. Journal of Molecular Endocrinology 27 11-29.
37. Sells SF, Han SS, Muthukkumar S, Maddiwar N Johnstone R, Boghaert E, Gillis D, Liu G, Nair P, Mormig S. et al. 1997 Expression and function of the leucine zipper protein Par-4 in apoptosis. Molecular and Cellular Biology 17 3823-3832.
38. Senkel S, Lucas B, Klein-Hitpass L & Ryffel GH 2005 Identification of target genes of the transcription factors HNF-1β and HNF-1α in a human embryonic kidney cell line. Biochimica et Biophysica Acta 1731 179-190.
39. Sheikh MS, Hollander MC & Fornance AJ Jr 2000 Role of Gadd45 in apoptosis. Biochemical Pharmacology 59 43-45.
40. Shih DQ, Screenan S, Munoz KN, Philipson L, Pontoglio M, Yaniv M, Polonsky KS & Stoffel M 2001 Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50 2472-2480.
41. Stoffers DA, Ferrer J, Clarke WL & Habener JF 1997 Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genetics 17 138-139.
42. Thomas H, Senkel S, Erdmann S, Arndt T, Turan G, Klein-Hitpass L & Ryffel GU 2004 Pattern of genes influenced by conditional expression ofthe transcription factors HNF6, HNF4alpha and HNF1beta in a pancreatic beta-cell line. Nucleic Acids Research 32 e150.
43. Tomura H, Nishigori H, Sho K, Yamagata K, Inoue I & Takeda J 1999 Loss-of-function and dominant-negative mechanisms associated with hepatocyte nuclear factor-1beta mutations in familial type 2 diabetes mellitus. Journal of Biological Chemistry 274 12975-12978.
44. Waeber G, Thompson N, Nicod P & Bonny C 1996 Transcriptional activation ofthe GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Journal of Molecular Endocrinology 10 1327-1334.
45. Wang H, Maechler P, Hagenfeldt KA & Wollheim CB 1998 Dominant-negative suppression of HNF-1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta-cell line. EMBO Journal 17 6701-6713.
46. Wang L, Coffinier C, Thomas MK, Gresh L, Eddu G, Manor T, Levitsky LL, Yaniv M & Rhoads DB 2004 Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release. Endocrinology 145 3941-3949.
47. Wang H, Iezzi M, Theander S, Antinozzi PA, Gauthier BR, Halban PA & Wollheimn CB 2005 Suppression of Pdx-1 perturbs proinsulin processing, insulin secretion and GLP-1 signalling in INS-1 cells. Diabetologia 48 720-731.
48. Watada H, Kajimoto Y, Miyagawa J, Hanafusa T, Hamaguchi K, Matsuoka T, Yamamoto K, Matsuzawa Y, Kawamori R & Yamasaki Y 1996 PDX-1 induces insulin and glucokinase gene expressions in a1phaTC1 clone 6 cells in the presence of betacellulin. Diabetes 45 1826-1831.
49. Wild W, Pogge von Strandmann E, Nastos A, Senkel S, Lingott-Frieg A, Bulman M, Bingham C, Ellard S, Hattersley AT & Ryffel GU 2000 The mutated human gene encoding hepatocyte nuclear factor 1beta inhibits kidney formation in developing Xenopus embryos. PNAS 97 4695-4700.
50. Wobser H, Dussmann H, Kogel D, Wang H, Reimertz C, Wollheim CB, Byrne MM & Prehn JH 2002 Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide, but not to high glucose-induced cell death. Journal of Biological Chemistry 277 6413-6421.
51. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M & Bell GI 1996a Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes ofthe young (MODY1). Nature 384 458-460.
52. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV et al. 1996b Mutations in the hepatocyte nuclear factor-1 alpha gene in maturicy-onset diabetes of the young (MODY3). Nature 384 455-458.
53. Yang Q, Yamagata K, Fukui K, Cao Y, Nammo T, Iwahashi H, Wang H, Matsumura I, Hanafusa T, Bucala R et al. 2002 Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes 51 1785-1792.